Amphastar Pharmaceuticals Inc’s filing revealed that its Director Petersen Floyd F. acquired Company’s shares for reported $14430.0 on Apr 01 ’25. In the deal valued at $28.86 per share,500 shares were bought.
Then, Petersen Floyd F. sold 1,000 shares, generating $27,986 in total proceeds. Upon selling the shares at $27.99, the Director now owns 74,409 shares.
Before that, PETERS WILLIAM J sold 4,231 shares. Amphastar Pharmaceuticals Inc shares valued at $116,515 were divested by the CFO, EVP & TREASURER at a price of $27.54 per share. As a result of the transaction, PETERS WILLIAM J now holds 97,363 shares, worth roughly $2.75 million.
Piper Sandler downgraded its Amphastar Pharmaceuticals Inc [AMPH] rating to a Neutral from a an Overweight in a research note published on February 04, 2025; the price target was decreased to $36 from $66. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in late November with a ‘”an Equal weight”‘ rating. JP Morgan began covering AMPH with “an Overweight” recommendation on March 05, 2024. BofA Securities started covering the stock on November 17, 2023. It rated AMPH as “a Neutral”.
Price Performance Review of AMPH
On Tuesday, Amphastar Pharmaceuticals Inc [NASDAQ:AMPH] saw its stock fall -2.41% to $28.29. Over the last five days, the stock has lost -0.35%. Amphastar Pharmaceuticals Inc shares have fallen nearly -23.81% since the year began. Nevertheless, the stocks have fallen -35.57% over the past one year. While a 52-week high of $53.96 was reached on 01/15/25, a 52-week low of $25.89 was recorded on 03/13/25. SMA at 50 days reached $30.88, while 200 days put it at $40.62.
Levels Of Support And Resistance For AMPH Stock
The 24-hour chart illustrates a support level at 27.88, which if violated will result in even more drops to 27.48. On the upside, there is a resistance level at 28.98. A further resistance level may holdings at 29.67. The Relative Strength Index (RSI) on the 14-day chart is 43.51, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.61, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 28.91%. Stochastics %K at 83.91% indicates the stock is a selling.
How much short interest is there in Amphastar Pharmaceuticals Inc?
A steep rise in short interest was recorded in Amphastar Pharmaceuticals Inc stocks on 2025-03-14, dropping by -0.22 million shares to a total of 3.85 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 4.07 million shares. There was a decline of -5.69%, which implies that there is a negative sentiment for the stock.
